UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5376
CALL
Huntsman Corp
HUN
$1.66B
| $1.43M | ﹤0.01% |
134,500
-579,900
| -81% | -$7.99M |
2026 Q1
1 quarter
|
|
5377
Tenax Therapeutics
TENX
$63.2M
| $1.43M | ﹤0.01% |
98,143
-283,276
| -74% | -$3.62M |
2024 Q1
9 quarters
|
|
5378
SAB Biotherapeutics
SABS
$276M
| $1.43M | ﹤0.01% |
365,878
+319,255
| +685% | +$1.19M |
2024 Q4
6 quarters
|
|
5379
Destiny Tech100
DXYZ
$742M
| $1.43M | ﹤0.01% |
55,374
+21,185
| +62% | +$797K |
2024 Q4
6 quarters
|
|
5380
Zhihu
ZH
$229M
| $1.42M | ﹤0.01% |
454,892
+7,082
| +2% | +$22.8K |
2021 Q2
20 quarters
|
|
5381
PUT
BrightSpire Capital
BRSP
$416M
| $1.42M | ﹤0.01% |
260,000
+160,000
| +160% | +$917K |
2026 Q1
1 quarter
|
|
5382
Cronos Group
CRON
$1.33B
| $1.41M | ﹤0.01% |
508,976
+13,398
| +3% | +$35.9K |
2018 Q1
33 quarters
|
|
5383
Grid Dynamics Holdings
GDYN
$1.05B
| $1.41M | ﹤0.01% |
249,091
-248,143
| -50% | -$1.54M |
2020 Q4
22 quarters
|
|
5384
Pangaea Logistics
PANL
$496M
| $1.41M | ﹤0.01% |
217,209
-252,289
| -54% | -$1.91M |
2023 Q1
13 quarters
|
|
5385
iShares Currency Hedged MSCI Emerging Markets
HEEM
$267M
| $1.41M | ﹤0.01% |
31,560
+4,670
| +17% | +$197K |
2015 Q1
45 quarters
|
|
5386
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$284M
| $1.41M | ﹤0.01% |
23,580
-3,066
| -12% | -$159K |
2014 Q4
46 quarters
|
|
5387
Orchestra BioMed
OBIO
$341M
| $1.41M | ﹤0.01% |
325,773
+275,463
| +548% | +$1.13M |
2023 Q2
12 quarters
|
|
5388
One Liberty Properties
OLP
$462M
| $1.4M | ﹤0.01% |
57,533
-9,047
| -14% | -$211K |
2014 Q4
46 quarters
|
|
5389
Acco Brands
ACCO
$467M
| $1.4M | ﹤0.01% |
337,565
-81,531
| -19% | -$299K |
2014 Q4
46 quarters
|
|
5390
National CineMedia
NCMI
$149M
| $1.4M | ﹤0.01% |
368,344
+10,416
| +3% | +$35.5K |
2014 Q4
46 quarters
|
|
5391
Pacer US Large Cap Cash Cows Growth Leaders ETF
COWG
$2.17B
| $1.4M | ﹤0.01% |
34,835
+6,078
| +21% | +$226K |
2025 Q1
5 quarters
|
|
5392
CALL
Guardant Health
GH
$20.2B
| $1.4M | ﹤0.01% |
9,300
| – | – |
2026 Q1
1 quarter
|
|
5393
CALL
SBA Communications
SBAC
$19.8B
| $1.39M | ﹤0.01% |
+7,900
| New | +$1.63M |
2026 Q2
0 quarters
|
|
5394
SCHMID Group
SHMD
$143M
| $1.39M | ﹤0.01% |
222,358
+66,786
| +43% | +$410K |
2025 Q4
2 quarters
|
|
5395
Phibro Animal Health
PAHC
$1.34B
| $1.39M | ﹤0.01% |
44,310
+5,247
| +13% | +$221K |
2014 Q4
46 quarters
|
|
5396
PUT
Intercontinental Exchange
ICE
$96.3B
| $1.39M | ﹤0.01% |
11,300
-8,700
| -44% | -$1.31M |
2018 Q1
33 quarters
|
|
5397
Korro Bio
KRRO
$217M
| $1.39M | ﹤0.01% |
105,453
+83,777
| +386% | +$1.04M |
2019 Q4
26 quarters
|
|
5398
Global X MSCI Colombia ETF
COLO
$173M
| $1.39M | ﹤0.01% |
33,336
+27,590
| +480% | +$1.11M |
2025 Q1
5 quarters
|
|
5399
CALL
Monolithic Power Systems
MPWR
$58.1B
| $1.38M | ﹤0.01% |
1,000
-500
| -33% | -$751K |
2026 Q1
1 quarter
|
|
5400
Net Lease Office Properties
NLOP
$137M
| $1.38M | ﹤0.01% |
124,079
+109,979
| +780% | +$1.33M |
2023 Q4
10 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.